Financials

Discussions Technicals Seasonals

6744 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Feng Chi Biotech Corp. engages in the provision of neonatal genetic disease testing, new born screening, life science and microbiological testing services. It focuses on colorectal cancer, lung cancer; scientific research genetic testing and development. The company was founded on May 12, 1992 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

6744 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company